Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Antidepressants substantially affect basic REM sleep characteristics in narcolepsy-cataplexy patients
Jitka Busková1, David Kemlink1, Veronika Ibarburu1
1Department of Neurology and Center for Clinical Neurosciences, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
Antidepressant use in narcolepsy with cataplexy patients significantly increases the risk of developing REM sleep behavior disorder (RBD). This study found a three-fold higher occurrence of RBD in patients with a history of antidepressant use compared to those who were antidepressant-naïve.
Area of Science:
- Neurology
- Sleep Medicine
- Pharmacology
Background:
- Antidepressants can alter REM sleep and induce REM sleep behavior disorder (RBD) in the general population.
- Antidepressants are often prescribed to manage cataplexy in narcolepsy with cataplexy (NC).
Purpose of the Study:
- To investigate the association between antidepressant use and the development of RBD in patients diagnosed with narcolepsy with cataplexy (NC).
Main Methods:
- Seventy-five NC patients underwent structured interviews regarding RBD manifestations and antidepressant history.
- Night video-polysomnography and multiple sleep latency tests were performed for assessment.
Main Results:
- 45.3% of NC patients reported antidepressant use; 38.2% of these developed RBD.
- Only 12.2% of antidepressant-naïve NC patients were diagnosed with RBD.
- Antidepressant use was linked to increased REM latency, reduced REM sleep percentage, and more periodic limb movements during sleep.
Conclusions:
- NC patients with a history of antidepressant use exhibit a threefold higher incidence of RBD compared to antidepressant-naïve patients.
- Antidepressant use is a significant risk factor for RBD development in narcolepsy with cataplexy.
Related Concept Videos
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
REM Sleep Behavior Disorder
RBD is significantly associated with...

